Michael T. Milano

Michael T. Milano, M.D., Ph.D. is a Professor in the Department of Radiation Oncology at the University of Rochester School of Medicine and Dentistry. He is affiliated with the University of Rochester Medical Faculty Group (URMFG) and Accountable Health Partners (AHP), providing specialized care for cancer patients at the Wilmot Cancer Institute. Dr. Milano is a native Rochesterian who attended McQuaid Jesuit High School and completed his medical training at the University of Rochester.

Dr. Milano earned his MD from the University of Rochester School of Medicine/Dentistry in 2000, completed an Internal Medicine internship at the University of Rochester Medical Center (2000-2001), and a Radiation Oncology residency at the University of Chicago, Pritzker School of Medicine (2001-2005).

His research focuses on advanced radiation therapy techniques, particularly stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS) for complex cancers. Dr. Milano's expertise includes thoracic tumors, central nervous system tumors, and oligometastatic disease. His work addresses critical questions about radiation dose-volume relationships, clinical practice guidelines, and the integration of radiation therapy with systemic treatments. He has made significant contributions to understanding radiation effects in pediatric patients through the Pediatric Normal Tissue Effects in the Clinic (PENTEC) initiative.

Analysis of Dr. Milano's recent publications reveals a strong emphasis on precision radiation therapy for brain and spinal tumors, oligometastatic disease, and complex thoracic malignancies. His work frequently appears in high-impact journals and involves multi-institutional collaborations. A notable trend is his contribution to developing clinical practice guidelines through organizations like ASTRO and the American Radium Society. His research increasingly integrates molecular biomarkers with radiation treatment outcomes to personalize therapy.

• Outstanding Reviewer in 2018 from Int J Radiat Oncol Biol Phys (2019)
• Rubin-Mitchell Teaching Award (2008)
• Teacher of the Year Award (2008)
• Simon Kramer New Investigator Award (2009)
• George V. Metzger Award (1999)
• Patient- and Family-Centered Care Award (2012)

Dr. Milano has been actively involved in mentoring trainees and collaborating on numerous research projects. His work with the PENTEC initiative demonstrates his commitment to understanding and minimizing radiation effects, particularly in vulnerable populations. He has contributed to multiple clinical practice guidelines that help standardize radiation therapy approaches for various cancer types, particularly in neuro-oncology and oligometastatic disease.

At the Wilmot Cancer Institute, Dr. Milano provides compassionate, personalized care recognizing that 'every patient and every cancer is unique.' His clinical practice focuses on using cutting-edge radiation technology to treat cancer patients, with particular expertise in thoracic and central nervous system tumors. He treats conditions including benign and malignant brain tumors, spine tumors, lung cancer, and oligometastases.